Multimodal visualization agents designed to enhance image-guided high-precision cancer therapy including surgery, radiotherapy, and chemotherapy
迷雾通-迷雾通加速器官网-迷雾通vpm-迷雾通app安卓下载-迷雾通
Learn how Nanovista’s proprietary technology illuminate tumors both at the planning stage and inside the operating room.
迷雾通-迷雾通加速器官网-迷雾通vpm-迷雾通app安卓下载-迷雾通
- Sector: Oncology/Image-guided interventions
- ip加速器破解 Multimodal imaging agent for cancer surgery and image-guided intervention
- Market Size: $2.7 Billion by 2024
- Development Stage: Pre-IND
迷雾通-迷雾通加速器官网-迷雾通vpm-迷雾通app安卓下载-迷雾通
Nanovista Team
Email: info@nanovista.com